Cohen-Bucay A

Idioma: Español
Referencias bibliográficas: 36
Paginas: 53-60
Archivo PDF: 225.57 Kb.

FRAGMENTO

La enfermedad renal crónica es un factor de riesgo independiente de enfermedad coronaria dado que la incidencia y severidad de enfermedad coronaria aumenta conforme la tasa de filtrado glomerular disminuye.1,2 En pacientes asintomáticos con enfermedad renal crónica terminal (ERCT), la prevalencia de estenosis arterial coronaria es de 37 a 58%.3 En el periodo postrasplante, se le atribuye 30% de las muertes a enfermedad cardiovascular, siendo así la principal causa de muerte en receptores de trasplante renal.4 La incidencia acumulada de infarto a miocardio dentro de los tres años después del trasplante es de 4.2 a 11.1%.5,6 Ya que la incidencia/prevalencia, así como la morbilidad y mortalidad asociada con enfermedad cardiovascular es tan elevada en los pacientes con enfermedad renal crónica terminal y en receptores de trasplante renal, es necesario realizar una evaluación cardiovascular en todos los potenciales receptores.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Nakano T, Ninomiya T, Sumiyoshi S et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am J Kidney Dis. 2010; 55: 21-30.

2. Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA, Kressin NR. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol. 2008; 28 (2): 354-360.

3. Ramphul R, Fernández M, Firoozi S, Kaski JC, Sharma R, Banerjee D. Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol. BMC Nephrol. 2018; 19: 2.

4. Lentine KL, Costa SP, Weir MR et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012; 60: 434-480.

5. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005; 16: 496-506.

6. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol. 2006; 17: 900-907.

7. John R, Lietz K, Huddleston S et al. Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients. J Thorac Cardiovasc Surg. 2007; 133: 1212-1219.

8. Zhang L, Garcia JM, Hill PC, Haile E, Light JA, Corso PJ. Cardiac surgery in renal transplant recipients: experience from Washington Hospital Center. Ann Thorac Surg. 2006; 81: 1379-1384.

9. Mitruka SN, Griffith BP, Kormos RL et al. Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997; 64: 1270-1278.

10. Massad M, Kpodonu J, Lee J et al. Outcome of coronary artery bypass operations in patients with renal insufficiency with and without renal transplantation. Chest. 2005; 128: 855-862.

11. Cohen-Bucay A, Gordon CE, Francis JM. Non-immunological complications following kidney transplantation. F1000Res. 2019; 8.

12. Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int. 2004; 66: 441-447.

13. Kiberd B, Panek R. Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. Clin J Am Soc Nephrol. 2008; 3: 822-828.

14. Wang LW, Fahim MA, Hayen A et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. 2011: CD008691.

15. Rosario MA, Lima JJ, Parga JR et al. Coronary calcium score as predictor of stenosis and events in pretransplant renal chronic failure. Arq Bras Cardiol. 2010; 94: 236-243, 52-60, 9-47.

16. Winther S, Bottcher M, Jorgensen HS et al. Coronary calcium score may replace cardiovascular risk factors as primary risk stratification tool before kidney transplantation. Transplantation. 2016; 100: 2177-2187.

17. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant. 2004; 19: 2307-2312.

18. Sharples EJ, Pereira D, Summers S et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis. 2004; 43 (2): 313-319.

19. Iio K, Nagasawa Y, Kimura T et al. Assessment of coronary stenosis by a 16-slice MDCT scanner in asymptomatic diabetic patients starting dialysis therapy. Nephron Clin Pract. 2008; 109: c72-79.

20. Wang LW, Masson P, Turner RM et al. Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation. 2015; 99: 731-745.

21. Joki N, Hase H, Saijyo T et al. Combined assessment of cardiac systolic dysfunction and coronary atherosclerosis used to predict future cardiac deaths after starting hemodialysis. Am J Nephrol. 2003; 23 (6): 458-465.

22. Yamada S, Ishii H, Takahashi H et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010; 5: 1793-1798.

23. Wali RK, Wang GS, Gottlieb SS et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005; 45: 1051-1060.

24. Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008; 86: 1384-1388.

25. Lentine KL, Villines TC, Axelrod D, Kaviratne S, Weir MR, Costa SP. Evaluation and management of pulmonary hypertension in kidney transplant candidates and recipients: concepts and controversies. Transplantation. 2017; 101: 166-181.

26. Boudville N, Prasad GV, Knoll G et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006; 145: 185-196.

27. O’Keeffe LM, Ramond A, Oliver-Williams C et al. Mid- and long-term health risks in living kidney donors: a systematic review and meta-analysis. Ann Intern Med. 2018; 168: 276-284.

28. Young A, Storsley L, Garg AX et al. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant. 2008; 8: 1878-1890.

29. Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71: e13-e115.

30. Sanchez OA, Ferrara LK, Rein S, Berglund D, Matas AJ, Ibrahim HN. Hypertension after kidney donation: Incidence, predictors, and correlates. Am J Transplant. 2018; 18: 2534-2543.

31. Lentine KL, Schnitzler MA, Xiao H et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med. 2010; 363: 724-732.

32. Anjum S, Muzaale AD, Massie AB et al. Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am J Transplant. 2016; 16: 3540-3547.

33. Gracida C, Espinoza R, Cedillo U, Cancino J. Kidney transplantation with living donors. Transplantation Proceedings. 2003; 35: 946-947.

34. Lee JH, Kim SC, Han DJ et al. Risk factors for MDRD-GFR of less than 60 mL/min per 1.73 m2 in former kidney donors. Nephrology (Carlton). 2007; 12: 600-606.

35. Textor SC, Taler SJ, Driscoll N et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation. 2004; 78: 276-282.

36. Segev DL, Muzaale AD, Caffo BS et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303: 959-966.